What Is BPC-157? The Complete Guide

BPC-157, short for Body Protection Compound 157, is a synthetic pentadecapeptide — a chain of fifteen amino acids — derived from a naturally occurring protective protein found in human gastric juice. Over the last two decades it has moved from obscure Croatian research labs to the center of a growing conversation among sports medicine physicians, orthopedic specialists, and longevity clinics. This guide covers what BPC-157 actually is, the mechanisms that drive its healing effects, the documented primary uses, and the questions patients should be asking before any compounded peptide enters their body.

What BPC-157 Actually Is

BPC-157 is a fragment of a larger protein called Body Protection Compound, which was isolated from human gastric juice in the early 1990s. Researchers observed that the parent protein appeared to protect the gastrointestinal lining from a range of insults, including alcohol, NSAIDs, and stress ulceration. By isolating the active fifteen-amino-acid sequence, they produced a stable, synthesizable peptide that retained the parent protein’s cytoprotective and regenerative properties. Unlike many peptides, BPC-157 is remarkably stable in human gastric juice, which has prompted research into both oral and injectable forms.

How BPC-157 Works: The VEGFR2/Akt-eNOS Axis

The most well-characterized mechanism of BPC-157 involves angiogenesis — the formation of new blood vessels. Peer-reviewed research has shown that BPC-157 upregulates vascular endothelial growth factor receptor 2, commonly abbreviated as VEGFR2. Activation of this receptor triggers a downstream signaling cascade through the Akt and endothelial nitric oxide synthase (eNOS) pathway. The practical result is increased microvascular blood flow to injured tissue, improved oxygen and nutrient delivery, and accelerated recruitment of the cellular machinery responsible for tissue repair.

Beyond angiogenesis, BPC-157 appears to modulate growth hormone receptor expression in fibroblasts and tenocytes, which may explain its observed effects on tendon and ligament healing. It also interacts with the nitric oxide system, the dopaminergic system, and several inflammatory pathways, which is why the published research spans such a wide range of conditions.

Primary Therapeutic Uses

Tendon, Ligament, and Muscle Injury

The majority of published BPC-157 research focuses on musculoskeletal repair. Animal studies have demonstrated accelerated healing of transected Achilles tendons, medial collateral ligaments, and injured quadriceps muscle. The mechanism is attributed to both the VEGFR2-driven angiogenesis described above and the direct upregulation of growth hormone receptors in tendon cells. Clinicians working with athletes and chronic-injury patients have adopted BPC-157 as a supportive therapy alongside conventional physical rehabilitation.

Gastrointestinal Repair

Given its origin in gastric juice, it is unsurprising that BPC-157 shows potent gastroprotective effects. Research documents its ability to accelerate healing of gastric and duodenal ulcers, reduce NSAID-induced GI damage, and support repair of esophageal and colonic tissue in animal models of inflammatory bowel disease. This is one of the few peptides with meaningful data supporting oral administration, because it survives gastric acid and appears to act locally on GI tissue.

Neuroprotection and Systemic Effects

Animal studies have also shown neuroprotective effects in models of traumatic brain injury and spinal cord damage, though human data in this area remains limited. BPC-157 is best thought of as a supportive therapy — it does not replace surgical repair, structured rehabilitation, or conventional medical management. It may, however, shorten the timeline and improve the quality of healing.

Administration, Dosing, and Storage

Most USA-compounded BPC-157 is dispensed as a lyophilized powder that is reconstituted with bacteriostatic water before subcutaneous or intramuscular injection. Protocols vary by indication and should always be discussed with a qualified healthcare professional. Once reconstituted, BPC-157 should be refrigerated and used within the stability window documented on the pharmacy’s beyond-use date. Greenstone Peptides ships cold-chain to preserve the integrity of every compound.

Why USA-Compounded BPC-157 Matters

BPC-157 is one of the most commonly counterfeited peptides on the research market. Independent testing of samples purchased from unregulated online sellers has repeatedly shown purity levels ranging from nearly zero to the labeled concentration, with contamination from bacterial endotoxins, heavy metals, and unidentified synthesis byproducts. Injecting these into the body is a meaningful medical risk. Every BPC-157 vial dispensed through Greenstone Peptides is compounded inside a USP 797 compliant pharmacy, tested by an accredited analytical lab, and shipped with a batch-specific Certificate of Analysis.

The Bottom Line

BPC-157 is one of the more well-researched recovery peptides available today, with a plausible mechanism of action, decades of animal data, and a growing body of clinical experience. It is not a miracle drug. It is a tool — one that works best when sourced from a verified USA compounding pharmacy and used alongside a real rehabilitation plan. If you are considering BPC-157, the first question to ask is not about dosing. It is about where the vial came from.

The difference between a peptide that heals and a peptide that harms is the pharmacy that made it.

Sources

1. Sikiric P et al. — "Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract" — Current Pharmaceutical Design, 2011. pubmed.ncbi.nlm.nih.gov/21548867/

2. Sikiric P et al. — "Stable Gastric Pentadecapeptide BPC 157 and Wound Healing" — Frontiers in Pharmacology, 2021. pubmed.ncbi.nlm.nih.gov/34267654/

3. Chang CH et al. — "Pentadecapeptide BPC 157 Enhances Growth Hormone Receptor Expression in Tendon Fibroblasts" — Molecules, 2019. pmc.ncbi.nlm.nih.gov/articles/PMC6271067/